World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
152
Citations
115721
World Ranking
1061
National Ranking
609

Douglas Galasko publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Douglas Galasko sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 625 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Douglas Galasko D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas Galasko sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 152 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Douglas Galasko is affiliated with the University of California, San Diego in the United States. Their research contributions focus primarily on the field of Medicine, with a significant emphasis on Neurology and related subfields.

The main areas of study for this scientist include:

  • Neurology
  • Psychiatry and Mental health
  • Physiology
  • Molecular Biology
  • Genetics

Douglas Galasko's work covers a range of topics related to neurological diseases, with a particular focus on neurodegenerative disorders. Their key research topics are:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Neurological diseases and metabolism
  • Amyotrophic Lateral Sclerosis Research
  • Neuroinflammation and Neurodegeneration Mechanisms

The scientist has contributed to numerous publications in well-established venues, including:

  • Alzheimer s & Dementia
  • Neurology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Annals of Neurology
  • Journal of Alzheimer s Disease

Recent notable papers authored or coauthored include:

  • "Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group," 2021, The Lancet Neurology
  • "Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease," 2020, Nature
  • "Research criteria for the diagnosis of prodromal dementia with Lewy bodies," 2020, Neurology
  • "Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study," 2023, The Lancet Neurology
  • "Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study," 2020, Nature Communications

Douglas Galasko has frequently collaborated with several researchers, indicating a collaborative approach within their fields. Some of these frequent coauthors include:

  • Irene Litvan
  • David J. Irwin
  • Lawrence S. Honig
  • David P. Salmon
  • Bradley F. Boeve

Best Publications

  • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

    I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre

  • Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

    Katya Rascovsky;John R. Hodges;David Knopman;Mario F. Mendez

  • Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

    Bruno Dubois;Howard H. Feldman;Claudia Jacova;Steven T. DeKosky

  • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop

    I. G. Mckeith;D. Galasko;K. Kosaka;E. K. Perry

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel

  • Revising the definition of Alzheimer's disease: a new lexicon.

    Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings

  • Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

    Ronald C. Petersen;Ronald G. Thomas;Michael Grundman;David Bennett

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • The ageing systemic milieu negatively regulates neurogenesis and cognitive function

    Saul A. Villeda;Jian Luo;Kira I. Mosher;Bende Zou

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • Length of clinical trials of dementia drugs : Position paper from the international working group on harmonization of dementia drug guidelines

    Douglas Galasko;David Bennett;Mary Sano;Chris Ernesto

  • Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

    Raj N. Kalaria;Gladys E. Maestre;Gladys E. Maestre;Raul Arizaga;Robert P. Friedland

  • Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

    Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura

  • Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

    Michael Grundman;Ronald C. Petersen;Steven H. Ferris;Ronald G. Thomas

  • The Lewy body variant of Alzheimer's disease A clinical and pathologic entity

    L. Hansen;D. Salmon;D. Galasko;E. Masliah

  • Rehabilitation of hemiparesis after stroke with a mirror.

    Eric Lewin Altschuler;Sidney B Wisdom;Lance Stone;Chris Foster

  • An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

    Galasko D;Bennett D;Sano M;Ernesto C

  • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

    Ian G. McKeith

  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).: Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

    D. Galasko;S.D. Edland;J. C. Morris;C. Clark

Frequent Co-Authors

David P. Salmon
David P. Salmon University of California, San Diego
Elaine R. Peskind
Elaine R. Peskind University of Washington
Joseph F. Quinn
Joseph F. Quinn Oregon Health & Science University
Eliezer Masliah
Eliezer Masliah National Institutes of Health
James B. Leverenz
James B. Leverenz Cleveland Clinic
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Mark W. Bondi
Mark W. Bondi University of California, San Diego
Jeffrey Kaye
Jeffrey Kaye Oregon Health & Science University
Lawrence A. Hansen
Lawrence A. Hansen University of California, San Diego
John C. Morris
John C. Morris Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering Medicine in the USA, a variety of related online degrees and career pathways are available. With the evolving landscape of healthcare, many are opting for flexible learning programs that support their professional goals while accommodating busy schedules.

For those interested in mental health, several shortest online pmhnp programs allow you to earn credentials as a Psychiatric Mental Health Nurse Practitioner quickly and conveniently. Leadership-minded students may prefer healthcare administration degrees, which open doors to high-demand roles in healthcare management and policy.

Cost is another important factor. Prospective students can explore the cheapest mha online programs to gain vital skills for leadership positions, or consider the cheapest online bsn to dnp programs as a path to advanced nursing practice.

These diverse online options help you chart a personalized path in healthcare—whether in direct patient care, administration, or mental health specialties.

Best Scientists Citing Douglas Galasko

Trending Scientists

Recently Published Articles